Concepedia

Jeremy Reynoso

JR

Statistics

Publications

3

Citations

383

H-Index

3

Active since

2021

Affiliations

University of California, Los Angeles(Current)

Parker Institute for Cancer Immunotherapy

Jeremy Reynoso is an author at University of California, Los Angeles specializing in oncology, immune landscape profiling, and immune checkpoint inhibitors.

ORCID

Publications per year

2021–2023

3

Publications

3

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Lu Sun, Aaron Mochizuki, Jeremy Reynoso et al. · Nature Communications · 2021 · 261 citations · Full text

, , +17

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma

Junhui Hu, Ping Tan, Moe Ishihara et al. · Signal Transduction and Targeted Therapy · 2023 · 76 citations · Full text

, , +17

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Lu Sun, Jenny C. Kienzler, Jeremy Reynoso et al. · Journal of Clinical Investigation · 2023 · 46 citations · Full text

, , +17

1–3 of 3